Virtual Medicinal Product (VMP)
-
Avanafil 100mg tablets
Name Details
Current Name
Avanafil 100mg tablets
|
Start Date
08-04-2014
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G04BE10
BNF |
Current BNF
07040500
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
07040500
|
Start Date
25-06-2014
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42080511000001106 |
21-07-2023 |
|
703959000 |
02-04-2015 |
20-07-2023 |
24422211000001103 |
08-04-2014 |
01-04-2015 |
VMP Ingredients
VMP ingredients table
Avanafil |
Based on Ingredient Substance |
|
100 mg |
|
Name
Avanafil
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Avanafil
-
VMP
(Current) Avanafil 100mg tablets
Virtual Medicinal Product Pack (VMPP) Information